Long-term “real-life” safety of omalizumab in patients with severe uncontrolled asthma: A nine-year study
3 Marzo 2022 0
Danilo Di Bona a, *, Irene Fiorino a, Marialuisa Taurino b, Flavia Frisenda a, Elena Minenna b, Carlo Pasculli a, Georgios Kourtis a, Anna Simona Rucco a, Andrea Nico a, Marcello Albanesi a, Lucia Giliberti a, Luciana D’Elia b, Maria Filomena Caiaffa b, Luigi Macchia a